Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- longstanding and progressing symptoms
- headaches
- erectile dysfunction
- soft small testicles
- gynecomastia
- amenorrhea
- infertility
- breast atrophy
- loss of libido
- hot flashes
- diaphoresis
- weight gain
- fatigue
- anorexia
- nausea
- vomiting
- weakness
- decreased visual acuity
- bitemporal hemianopia
- pituitary apoplexy
- diplopia
Outros fatores diagnósticos
- increased central adiposity
- reduced muscle mass
- constipation
- cold intolerance
- dry skin
- hair loss
- poor memory
- low mood
- osteopenia
- weight loss
- nervousness
- facial numbness
- imbalance
- urinary incontinence
- recurrent sinusitis
- bradycardia
- seizures
Fatores de risco
- multiple endocrine neoplasia type 1 (MEN-1)
- familial isolated pituitary adenomas (FIPA)
- Carney complex (CNC)
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- prolactin
- insulin-like growth factor 1
- luteinising hormone, follicle-stimulating hormone
- alpha subunit of human pituitary glycoprotein hormones
- testosterone
- estradiol
- thyroid-stimulating hormone, free thyroxine
- morning cortisol
- adrenocorticotropic hormone stimulation test
- adrenocorticotropic hormone
- insulin tolerance test for cortisol
- basic metabolic panel
- CBC
- MRI pituitary with gadolinium enhancement
- contrast-enhanced CT pituitary
Investigações a serem consideradas
- growth hormone stimulation test
- lipid panel
- Humphrey or Goldmann formal visual fields test
- immunohistochemical staining
Algoritmo de tratamento
pituitary apoplexy
microadenoma
macroadenoma without mass effect and not abutting optic chiasm
macroadenoma without mass effect but abutting optic chiasm
macroadenoma with mass effect
Colaboradores
Autores
Susmeeta Tewari Sharma, MD, MBBS, MHSc
Director of Pituitary Endocrinology
MedStar Washington Hospital Center/Georgetown University Hospital
Washington
DC
Declarações
STS declares that she has no competing interests.
Agradecimentos
Dr Susmeeta Tewari Sharma would like to gratefully acknowledge Dr Gabriel Zada, Dr John Carmichael, Dr Israel Orija and Dr Amir H. Hamrahian, previous contributors to this topic. GZ, JC, IO and AH declare that they have no competing interests.
Revisores
S. Bulent Omay, MD
Assistant Professor of Neurosurgery
Yale Medical School
New Haven
CT
Declarações
SBO declares that he has no competing interests.
Andrew James, BSc, MB BCh, MD, MRCP, FRCP
Consultant Endocrinologist
Newcastle Hospitals NHS Foundation Trust
Royal Victoria Infirmary
Newcastle
UK
Declarações
AJ declares that he has no competing interests.
Federico Roncaroli, MD
Reader in Neuropathology and Honorary Consultant in Neuropathology
Neuropathology Unit
Department of Clinical Neuroscience
Division of Neuroscience and Mental Health
Faculty of Medicine
Imperial College
London
UK
Declarações
FR declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017 Feb 7;317(5):516-24. Resumo
Mercado M, Melgar V, Salame L, et al. Clinically non-functioning pituitary adenomas: pathogenic, diagnostic and therapeutic aspects. [in spa]. Endocrinol Diabetes Nutr. 2017 Aug-Sep;64(7):384-95. Resumo
Aghi MK, Chen CC, Fleseriu M, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on the management of patients with nonfunctioning pituitary adenomas: executive summary. Neurosurgery. 2016 Oct;79(4):521-3.Texto completo Resumo
Esposito D, Olsson DS, Ragnarsson O, et al. Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary. 2019 Aug;22(4):422-34.Texto completo Resumo
Minniti G, Flickinger J. The risk/benefit ratio of radiotherapy in pituitary tumors. Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101269. Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Prolactin-secreting adenoma (prolactinoma)
- Growth hormone-secreting adenoma (acromegaly)
- Adrenocorticotropic hormone-secreting adenoma (Cushing syndrome)
Mais Diagnósticos diferenciaisDiretrizes
- Clinical practice guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
- Appropriateness Criteria: neuroendocrine imaging
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal